| [1] |
Gilron I, Watson C P, Cahill C M,et al. Neuropathic pain: a practical guide for the clinician[J]. CMAJ, 2006,175(3): 265-275.
|
| [2] |
Troels S J, Ralf B, Maija H, et al. A new definition of neuropathic pain[J]. Pain, 2011, 152(10): 2204-2205.
|
| [3] |
Koen D, Ronny B, Sing L, et al.Mental disorders among persons with chronic back of neck pain: results from the world mental health surveys[J]. Pain, 2007,129 (3): 332-342.
|
| [4] |
Liu X, Liu H J, Xu S S, et al. Spinal translocator protein alleviates chronic neuropathic pain behavior and modulates spinal astrocyte-neuronal function in rats with L5 spinal nerve ligation model[J]. Pain, 2016, 157(1):103-116.
|
| [5] |
樊碧发. 神经病理性疼痛的诊疗[J]. 现代实用医学, 2010, 22(2):126-129.
|
| [6] |
Whitley R J, Volpi A, McKendrick M, et al.Managementof herpes zoster and post-herpetic neuralgia now and inthe future[J]. J Clin Virol, 2010, 48(1):20-28.
|
| [7] |
Ettinger A B, Argoff C E. Use of antiepileptic drugs for nonepileptic conditions:psychiatric disorders and chronic pain [J]. Neurother, 2007, 4(1): 75-83.
|
| [8] |
谭 刚, 郭向阳, 罗爱伦. 神经病理性疼痛药物治疗的现状[J]. 中华外科杂志, 2005,43(7): 474-476.
|
| [9] |
Xiao L, Mackey S, Hui H, et al.Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia[J].Pain Med,2010,11(1):1827-1833.
|
| [10] |
Dworkin R H,O'Connor A B,Backonja M,et al.Pharmac-ologic management of neuropathic pain:evidence-based proposal[J].Pain, 2005,118(3):289-305.
|
| [11] |
Kawamata T, Omote K, Yamamoto H, et al.Antihyperal-gesic and side effects of intrathecal clonidine and tizanidine in a rat model of neuropathic pain[J].Anesthesiology,2003, 98(6):1480-1483.
|
| [12] |
任 鹏, 孙 立, 郭 航, 等. 产后抑郁症的靶向治疗研究进展 [J]. 武警医学, 2018, 29(7): 729-732.
|
| [13] |
Zhang L M, Zhao N, Guo W Z, et al. Antidepressant-like and anxiolytic-like effects of YL-IPA08,a potent ligand for thetranslocator protein(18kDa)[J]. Neurop, 2014, 81(6): 116-125.
|
| [14] |
Rupprecht R, Papadopoulos V, Rammes G, et al. Translocator protein(18 kDa) (TSPO) as a therapeutic target for neurological andpsychiatric disorders [J].Nat Rev Drug Discov, 2010, 9(12): 971-988.
|
| [15] |
徐霜霜,刘晓明,程祝强,等. 鞘内注射转运蛋白配体对神经病理性疼痛的调节作用及其机制[J]. 中国疼痛医学杂志, 2015, 21(5): 346-350.
|
| [16] |
Ayikoe G, Mensah N, Laurence M,et al. Evidence for a key role of steroids in the modulation of pain [J]. Psychoneuroendocrinology, 2009, 34(S):169-177.
|
| [17] |
Meng Z,Jia L,MengM Z, et al. Elevated neurosteroids in the lateral thalamus relieve neuropathic pain in rats with spared nerve injury [J]. N B, 2016, 32(4):311-322.
|
| [18] |
Giatti S, Mcavaletti P.Neuroprotective effects of a ligand of translocator protein-18k Da (Ro5-4864)in experimental diabetic neuropathy[J].Neuroscience, 2009, 164 (2):520-529.
|
| [19] |
María F, María L,Sánchez G, et al. Temporal changes in the expression of the translocator protein TSPO and the steroidogenic enzyme 5-reductase in the dorsal spinal cord of animals with neuropathic pain: effects of progesterone administration [J]. Neurosci Lett, 2016, 624(1): 23-28.
|
| [20] |
Ma B J, Liu X M, Huang X, et al. Translocator protein agonist Ro5-4864 alleviates neuropathic pain and promotes remyelination in the sciatic nerve [J]. Mol Pain, 2018, 14:1744806917748019.
|
| [21] |
Ipek Y, Yohann B, Elisabeth W, et al. A time-dependent history of mood disorders in a murine model of neuropathic pain[J]. Biopsych, 2011,70(2): 946-953.
|
| [22] |
倪雪珺, 杜冬萍. 神经病理性疼痛与抑郁和焦虑精神症状的相关性[J].上海交通大学学报(医学版), 2013, 33(1): 67-70.
|
| [23] |
Wang D S, Tian Z, Guo Y Y, et al. Anxiolytic-like effects of translocator protein (TSPO) ligand ZBD-2 in an animal model of chronic pain [J]. Mol Pain, 2015, 11, PMC 4393609.
|
| [24] |
Bian F, Li Z, Offord J, et al. Calcium channel alpha2-delta type 1subunit is the major binding protein for pregabalin in neocortex, hippocampus,amygdala,and spinal cord:an ex vivo autoradiographic study in alpha2-delta type 1genetically modified mice[J]. Brain Res, 2006,1075(1): 68-80.
|
| [1] |
. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(3): 268-272. |
|
|
|
2020, Vol. 31 
